Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 19 |
NetGPI | no | yes: 0, no: 19 |
Term | Name | Level | Count |
---|---|---|---|
GO:0020022 | acidocalcisome | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: E9ARY2
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 14 |
GO:0043167 | ion binding | 2 | 13 |
GO:0043169 | cation binding | 3 | 13 |
GO:0046872 | metal ion binding | 4 | 13 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004842 | ubiquitin-protein transferase activity | 4 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0019787 | ubiquitin-like protein transferase activity | 3 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 383 | 387 | PF00656 | 0.481 |
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.479 |
CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.524 |
CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.549 |
CLV_NRD_NRD_1 | 88 | 90 | PF00675 | 0.571 |
CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.419 |
CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.548 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.507 |
CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.518 |
DEG_APCC_DBOX_1 | 38 | 46 | PF00400 | 0.360 |
DOC_CYCLIN_RxL_1 | 37 | 47 | PF00134 | 0.380 |
DOC_MAPK_MEF2A_6 | 211 | 220 | PF00069 | 0.542 |
DOC_MAPK_MEF2A_6 | 245 | 254 | PF00069 | 0.450 |
DOC_MAPK_MEF2A_6 | 39 | 46 | PF00069 | 0.382 |
DOC_MAPK_NFAT4_5 | 39 | 47 | PF00069 | 0.381 |
DOC_USP7_MATH_1 | 187 | 191 | PF00917 | 0.668 |
DOC_USP7_MATH_1 | 333 | 337 | PF00917 | 0.723 |
DOC_USP7_MATH_2 | 183 | 189 | PF00917 | 0.465 |
DOC_USP7_UBL2_3 | 119 | 123 | PF12436 | 0.559 |
DOC_USP7_UBL2_3 | 368 | 372 | PF12436 | 0.655 |
DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.539 |
DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.540 |
LIG_14-3-3_CanoR_1 | 283 | 293 | PF00244 | 0.515 |
LIG_14-3-3_CanoR_1 | 39 | 43 | PF00244 | 0.584 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.405 |
LIG_FHA_1 | 14 | 20 | PF00498 | 0.583 |
LIG_FHA_1 | 22 | 28 | PF00498 | 0.500 |
LIG_FHA_1 | 317 | 323 | PF00498 | 0.712 |
LIG_FHA_2 | 127 | 133 | PF00498 | 0.434 |
LIG_FHA_2 | 285 | 291 | PF00498 | 0.560 |
LIG_GBD_Chelix_1 | 44 | 52 | PF00786 | 0.442 |
LIG_LIR_Gen_1 | 57 | 64 | PF02991 | 0.550 |
LIG_LIR_Nem_3 | 263 | 269 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 57 | 62 | PF02991 | 0.551 |
LIG_LIR_Nem_3 | 68 | 73 | PF02991 | 0.551 |
LIG_LRP6_Inhibitor_1 | 273 | 279 | PF00058 | 0.390 |
LIG_NRBOX | 145 | 151 | PF00104 | 0.501 |
LIG_PTB_Apo_2 | 265 | 272 | PF02174 | 0.408 |
LIG_PTB_Phospho_1 | 265 | 271 | PF10480 | 0.429 |
LIG_SH2_CRK | 235 | 239 | PF00017 | 0.539 |
LIG_SH2_CRK | 59 | 63 | PF00017 | 0.450 |
LIG_SH2_CRK | 70 | 74 | PF00017 | 0.460 |
LIG_SH2_GRB2like | 300 | 303 | PF00017 | 0.546 |
LIG_SH2_SRC | 90 | 93 | PF00017 | 0.496 |
LIG_SH2_STAP1 | 271 | 275 | PF00017 | 0.407 |
LIG_SH2_STAT3 | 125 | 128 | PF00017 | 0.536 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.448 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.409 |
LIG_SH3_3 | 153 | 159 | PF00018 | 0.668 |
LIG_SH3_3 | 172 | 178 | PF00018 | 0.489 |
LIG_SH3_3 | 292 | 298 | PF00018 | 0.570 |
LIG_SH3_3 | 90 | 96 | PF00018 | 0.379 |
LIG_SUMO_SIM_anti_2 | 41 | 47 | PF11976 | 0.426 |
LIG_TRAF2_1 | 129 | 132 | PF00917 | 0.457 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.476 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.472 |
MOD_CK1_1 | 336 | 342 | PF00069 | 0.634 |
MOD_CK1_1 | 346 | 352 | PF00069 | 0.799 |
MOD_CK2_1 | 126 | 132 | PF00069 | 0.455 |
MOD_CK2_1 | 284 | 290 | PF00069 | 0.560 |
MOD_CK2_1 | 353 | 359 | PF00069 | 0.747 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.479 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.587 |
MOD_GlcNHglycan | 189 | 192 | PF01048 | 0.672 |
MOD_GlcNHglycan | 228 | 232 | PF01048 | 0.628 |
MOD_GlcNHglycan | 348 | 351 | PF01048 | 0.709 |
MOD_GlcNHglycan | 378 | 381 | PF01048 | 0.740 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.425 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.488 |
MOD_GSK3_1 | 23 | 30 | PF00069 | 0.574 |
MOD_GSK3_1 | 332 | 339 | PF00069 | 0.593 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.424 |
MOD_N-GLC_1 | 139 | 144 | PF02516 | 0.436 |
MOD_N-GLC_1 | 333 | 338 | PF02516 | 0.754 |
MOD_NEK2_1 | 27 | 32 | PF00069 | 0.512 |
MOD_NEK2_1 | 284 | 289 | PF00069 | 0.480 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.429 |
MOD_OFUCOSY | 282 | 288 | PF10250 | 0.548 |
MOD_PIKK_1 | 123 | 129 | PF00454 | 0.402 |
MOD_PIKK_1 | 21 | 27 | PF00454 | 0.564 |
MOD_PIKK_1 | 333 | 339 | PF00454 | 0.614 |
MOD_PKA_2 | 346 | 352 | PF00069 | 0.621 |
MOD_PKA_2 | 373 | 379 | PF00069 | 0.536 |
MOD_PKA_2 | 38 | 44 | PF00069 | 0.581 |
MOD_Plk_1 | 108 | 114 | PF00069 | 0.448 |
MOD_Plk_1 | 139 | 145 | PF00069 | 0.458 |
MOD_Plk_1 | 262 | 268 | PF00069 | 0.432 |
MOD_Plk_2-3 | 101 | 107 | PF00069 | 0.426 |
MOD_Plk_4 | 27 | 33 | PF00069 | 0.588 |
MOD_Plk_4 | 353 | 359 | PF00069 | 0.473 |
MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.533 |
MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.542 |
MOD_SUMO_rev_2 | 111 | 120 | PF00179 | 0.529 |
MOD_SUMO_rev_2 | 75 | 80 | PF00179 | 0.551 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.417 |
TRG_ENDOCYTIC_2 | 70 | 73 | PF00928 | 0.421 |
TRG_ENDOCYTIC_2 | 90 | 93 | PF00928 | 0.389 |
TRG_ER_diArg_1 | 143 | 145 | PF00400 | 0.466 |
TRG_ER_diArg_1 | 38 | 40 | PF00400 | 0.537 |
TRG_ER_diArg_1 | 70 | 72 | PF00400 | 0.563 |
TRG_ER_diArg_1 | 87 | 89 | PF00400 | 0.546 |
TRG_ER_diLys_1 | 389 | 393 | PF00400 | 0.726 |
TRG_NES_CRM1_1 | 148 | 160 | PF08389 | 0.628 |
TRG_NES_CRM1_1 | 37 | 50 | PF08389 | 0.559 |
TRG_Pf-PMV_PEXEL_1 | 112 | 116 | PF00026 | 0.497 |
TRG_Pf-PMV_PEXEL_1 | 144 | 148 | PF00026 | 0.431 |
TRG_Pf-PMV_PEXEL_1 | 71 | 75 | PF00026 | 0.474 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1I4 | Leptomonas seymouri | 70% | 99% |
A0A0N1PG85 | Leptomonas seymouri | 32% | 100% |
A0A0S4KEK3 | Bodo saltans | 38% | 100% |
A0A1X0P6E1 | Trypanosomatidae | 36% | 100% |
A0A3Q8IA61 | Leishmania donovani | 31% | 100% |
A0A3R7RSV6 | Trypanosoma rangeli | 34% | 100% |
A0A3S7WVD2 | Leishmania donovani | 95% | 100% |
A0A422P3A2 | Trypanosoma rangeli | 40% | 96% |
A4H9Y7 | Leishmania braziliensis | 31% | 100% |
A4H9Y8 | Leishmania braziliensis | 71% | 100% |
A4HY39 | Leishmania infantum | 94% | 100% |
A4HY52 | Leishmania infantum | 33% | 100% |
D0A0F3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
D0A0F7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 91% |
E9ARY1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 95% |
Q4QDJ1 | Leishmania major | 30% | 97% |
V5BSB1 | Trypanosoma cruzi | 36% | 82% |
V5BWY8 | Trypanosoma cruzi | 33% | 100% |